| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 3.297 | 0 | 0 | 4.852 | 23.938 |
| Total Income - EUR | - | - | - | - | - | 3.297 | 0 | 0 | 4.852 | 23.941 |
| Total Expenses - EUR | - | - | - | - | - | 2.093 | 389 | -487 | 5.906 | 18.826 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.204 | -389 | 487 | -1.054 | 5.115 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.112 | -389 | 487 | -1.054 | 4.252 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Uf Farmaceutici S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 138 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 2.337 | 1.426 | 1.430 | 1.816 | 5.598 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.409 | 1.347 | 1.351 | 649 | 281 |
| Cash | - | - | - | - | - | 928 | 79 | 79 | 1.167 | 5.317 |
| Shareholders Funds | - | - | - | - | - | 1.360 | 941 | 1.430 | -326 | 3.928 |
| Social Capital | - | - | - | - | - | 248 | 243 | 243 | 243 | 241 |
| Debts | - | - | - | - | - | 1.115 | 485 | 0 | 2.143 | 1.670 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Uf Farmaceutici S.r.l.